Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 1995 July; 39(7): 1493–1498.
PMCID: PMC162769

Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits.


The purpose of this study was to evaluate the pharmacokinetics of ofloxacin in serum and vitreous humor samples from albino and pigmented rabbits by using a recently described animal model which permits robust estimation of parameter values. The drug was administered to rabbits intravenously, multiple vitreous humor and serum samples were taken from each rabbit, and the vitreous humor and serum samples were assayed by high-pressure liquid chromatography. The pharmacokinetic parameters were determined with RSTRIP, an iterative, nonlinear, weighted, least-squares regression program. Eight New Zealand White rabbits and eight Dutch Belted rabbits (split into single-dose and multiple-dose groups) were investigated in this study. The value of penetration into the vitreous humor of albino rabbits (n = 6) was 32.6% +/- 2.12%, with terminal-elimination half-life values of 3.21 and 2.39 h, respectively, for vitreous humor and serum. In pigmented rabbits after a single dose (n = 3) and with a steady-state concentration of drug in serum (n = 4), penetration values were similar, at 30.4% +/- 2.98% and 30.0% +/- 4.12%, respectively (P > 0.10). Following a single dose of ofloxacin, pigmented animals had elimination half-life values from serum and vitreous humor of 2.64 and 4.32 h, respectively. After steady state was achieved, half-life values for serum and vitreous humor were 3.12 and 6.05 h, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Full Text

The Full Text of this article is available as a PDF (208K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Badenoch PR, McDonald PJ, Coster DJ. Effect of inflammation on antibiotic penetration into the anterior segment of the rat eye. Invest Ophthalmol Vis Sci. 1986 Jun;27(6):958–965. [PubMed]
  • Barza M. Pharmacokinetics and efficacy of the new quinolones in infections of the eye, ear, nose, and throat. Rev Infect Dis. 1988 Jan-Feb;10 (Suppl 1):S241–S247. [PubMed]
  • Barza M, Kane A, Baum J. Comparison of the effects of continuous and intermittent systemic administration on the penetration of gentamicin into infected rabbit eyes. J Infect Dis. 1983 Jan;147(1):144–148. [PubMed]
  • Barza M, Kane A, Baum J. Marked differences between pigmented and albino rabbits in the concentration of clindamycin in iris and choroid-retina. J Infect Dis. 1979 Feb;139(2):203–208. [PubMed]
  • Borner K, Borner E, Lode H. Determination of sparfloxacin in serum and urine by high-performance liquid chromatography. J Chromatogr. 1992 Sep 2;579(2):285–289. [PubMed]
  • Bron A, Talon D, Delbosc B, Estavoyer JM, Kaya G, Royer J. La pénétration intracamérulaire de l'ofloxacine chez l'homme. J Fr Ophtalmol. 1987;10(6-7):443–446. [PubMed]
  • Cochereau-Massin I, Bauchet J, Faurisson F, Vallois JM, Lacombe P, Pocidalo JJ. Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits. Antimicrob Agents Chemother. 1991 Jun;35(6):1112–1115. [PMC free article] [PubMed]
  • Diamond JG. Intraocular management of endophthalmitis. A systematic approach. Arch Ophthalmol. 1981 Jan;99(1):96–99. [PubMed]
  • Driebe WT, Jr, Mandelbaum S, Forster RK, Schwartz LK, Culbertson WW. Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology. 1986 Apr;93(4):442–448. [PubMed]
  • el Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG, Liggett PE. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology. 1992 Apr;99(4):483–486. [PubMed]
  • Eng RH, Padberg FT, Smith SM, Tan EN, Cherubin CE. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother. 1991 Sep;35(9):1824–1828. [PMC free article] [PubMed]
  • Fukuda M, Sasaki K. Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes. Lens Eye Toxic Res. 1989;6(1-2):339–351. [PubMed]
  • Fisch A, Lafaix C, Salvanet A, Cherifi M, Meulemans A. Ofloxacin in human aqueous humour and lens. J Antimicrob Chemother. 1987 Sep;20(3):453–454. [PubMed]
  • Guy RH, Hadgraft J. Theoretical comparison of release rates of drugs into sink and nonsink conditions. J Pharm Sci. 1981 Nov;70(11):1243–1245. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Mandell BA, Meredith TA, Aguilar E, el-Massry A, Sawant A, Gardner S. Effects of inflammation and surgery on amikacin levels in the vitreous cavity. Am J Ophthalmol. 1993 Jun 15;115(6):770–774. [PubMed]
  • Martin DF, Ficker LA, Aguilar HA, Gardner SK, Wilson LA, Meredith TA. Vitreous cefazolin levels after intravenous injection. Effects of inflammation, repeated antibiotic doses, and surgery. Arch Ophthalmol. 1990 Mar;108(3):411–414. [PubMed]
  • Massin-Cochereau I, Le Hoang P, Weiser M, Rousselie F. Pefloxacine et infections oculaires graves. Bull Soc Ophtalmol Fr. 1987 Jun-Jul;87(6-7):735–738. [PubMed]
  • Mayers M, Rush D, Madu A, Motyl M, Miller MH. Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrob Agents Chemother. 1991 Sep;35(9):1791–1798. [PMC free article] [PubMed]
  • Menon IA, Trope GE, Basu PK, Wakeham DC, Persad SD. Binding of timolol to iris-ciliary body and melanin: an in vitro model for assessing the kinetics and efficacy of long-acting antiglaucoma drugs. J Ocul Pharmacol. 1989 Winter;5(4):313–324. [PubMed]
  • Miller MH, Madu A, Samathanam G, Rush D, Madu CN, Mathisson K, Mayers M. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits. Antimicrob Agents Chemother. 1992 Jan;36(1):32–38. [PMC free article] [PubMed]
  • Mishima S. Ocular effects of beta-adrenergic agents. XII Jules Stein Lecture. Surv Ophthalmol. 1982 Nov-Dec;27(3):187–208. [PubMed]
  • Mounier M, Ploy MC, Chauvin M, Adenis JP, Denis F. Etude de la pénétration intraoculaire de l'ofloxacine chez l'homme et le lapin. Pathol Biol (Paris) 1992 May;40(5):529–533. [PubMed]
  • Olson JC, Flynn HW, Jr, Forster RK, Culbertson WW. Results in the treatment of postoperative endophthalmitis. Ophthalmology. 1983 Jun;90(6):692–699. [PubMed]
  • Peyman GA, Schulman JA. Intravitreal drug therapy. Jpn J Ophthalmol. 1989;33(4):392–404. [PubMed]
  • Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis. Review of 36 cases. Ophthalmology. 1982 Aug;89(8):921–929. [PubMed]
  • Salvanet-Bouccara A, Feys J, Koffi-Gue B, Fisch A, Cherifi M, Forestier F. Endophtalmies bactériennes: traitement par l'association fosfomycine pefloxacine. A propos de 9 cas. Bull Soc Ophtalmol Fr. 1989 Nov;89(11):1281–1286. [PubMed]
  • Tulkens PM. Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):100–106. [PubMed]
  • Walsh A, Haft DA, Miller MH, Loran MR, Friedman AH. Ocular penetration of 5-fluorocytosine. Invest Ophthalmol Vis Sci. 1978 Jul;17(7):691–694. [PubMed]
  • Young P, Barza M, Kane A, Baum J. Radioactive and bioassay of intraocular antibiotics: double-assay technique to compare penicillin G, cefamandole, and gentamicin in ocular tissues in vivo. Arch Ophthalmol. 1979 Apr;97(4):717–720. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)